Centene Corporation CNC
61.82
(0.10)
(0.16%)
as of 25 Sep
- Market cap
- $30.6B
- P/E
- 0.0×
Follow CNC
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Centene Corporation (CNC) Net income
Centene Corporation's net income for fiscal 2025 was −$6.7B, compared with $3.3B in fiscal 2024. Over the twelve months to 30 June 2026 it was −$5.1B. Over the past ten years it has ranged from −$6.7B (fiscal 2025) to $3.3B (fiscal 2024) — the current reading is the lowest in ten years. Centene Corporation ranks 12th of 12 Healthcare Plans companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$6.7B | — |
| FY2024 | $3.3B | 22.05% |
| FY2023 | $2.7B | 124.54% |
| FY2022 | $1.2B | (10.03%) |
| FY2021 | $1.3B | (25.53%) |
| FY2020 | $1.8B | 37.05% |
| FY2019 | $1.3B | 46.42% |
| FY2018 | $894.0M | 10.64% |
| FY2017 | $808.0M | 44.03% |
| FY2016 | $561.0M | 57.14% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $1.1B | (29.37%) |
| Mar 2026 | $1.5B | — |
| Dec 2025 | −$1.1B | — |
| Sep 2025 | −$6.6B | — |
| 42 more quarters | Free account |
Against its own ten years
Low −$6.7B
High $3.3B
Ten-year median
$1.2B
Current reading's percentile
9
Net income against peers
| Company | Net income |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $14.9B |
| CI Cigna Group compare | $7.0B |
| ELV Elevance Health, Inc. compare | $4.9B |
| CVS CVS Health Corporation compare | $4.9B |
| HUM Humana Inc. compare | $1.3B |
| OSCR Oscar Health, Inc. compare | $550.9M |
| MOH Molina Healthcare, Inc compare | −$7.0M |
| CLOV Clover Health Investments, Corp. compare | −$18.4M |
| CNC Centene Corporation | −$5.1B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on CNC
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement